Organization
Istanbul University Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, Turkey
2 abstracts
Abstract
Health-related quality of life (HRQoL) and pain outcomes for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) who received abiraterone (abi) and olaparib (ola) versus (vs) abi and placebo (pbo) in the phase III PROpel trial.Org: CHRU Besançon Hôpital J.Minjoz, Besançon, France, Centre Hospitalier de l’Université de Montréal/CRCHUM, Université de Montreal, Montreal, QC, Canada, Duke Cancer Institute Center for Prostate and Urologic Cancer, Duke University, Durham, NC, Department of Urology, Keio University School of Medicine, Tokyo, Japan, Centro Integrado de Oncologia de Curitiba, Curitiba, Brazil,
Abstract
ANALYSIS OF NAILFOLD CAPILLAROSCOPY FINDINGS AND CLINICAL FEATURES OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND PULMONARY ARTERIAL HYPERTENSIONOrg: Bambino Gesu’ Children Hospital, Unit of Rheumatology, Rome, Italy, Heinrich-Heine-University Duesseldorf, University Hospital Dusseldorf, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy, Istanbul University Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, Turkey,